We are live on ! Find out more
CPAH

Counterpath Corp
CPAH

Delisted

CPAH was delisted on the 26th of February, 2021.

7 hedge funds and large institutions have $669K invested in Counterpath Corp in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding

Funds holding: 67 (+1)

6% more capital invested

Capital invested by funds: $632K → $669K (+$37K)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$440
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$594K
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$35K +$33.7K +15,300 +1,034%
Citadel Advisors
3
Citadel Advisors
Florida
$20K +$22K +10,004 New
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$18K
TRCT
5
Tower Research Capital (TRC)
New York
$2K -$440 -200 -18%

CPAH Hedge Fund Activity: Q3 2016 in Review

7 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Counterpath Corp (CPAH) for Q3 2016, worth a combined $669K — up 5.9% from $632K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CPAH positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Royal Bank of Canada, adding an estimated $33.7K. The largest seller was Tower Research Capital (TRC), cutting an estimated $440.

  • 7 institutional investors held Counterpath Corp (CPAH) as of Q3 2016, up from 6 in Q2 2016.
  • Funds reported $669K of Counterpath Corp stock for Q3 2016, up 5.9% quarter-over-quarter.
  • 1 fund opened new Counterpath Corp positions in Q3 2016 and 0 closed out, a net change of +1 holder.
  • The largest Counterpath Corp buyer in Q3 2016 was Royal Bank of Canada, an estimated $33.7K added.
  • The largest Counterpath Corp seller in Q3 2016 was Tower Research Capital (TRC), an estimated $440 sold.

Based on aggregated 13F filings for Q3 2016.